Work-Up and Antibiotic Regimen for Group A Streptococcal Pharyngitis
Diagnostic Confirmation Before Treatment
Laboratory confirmation with either a rapid antigen detection test (RADT) or throat culture is mandatory before prescribing antibiotics, because clinical features alone cannot reliably distinguish bacterial from viral pharyngitis. 1, 2
Age-Specific Testing Algorithms
- Children and adolescents (ages 5–15): Perform RADT first; if negative, obtain a backup throat culture because RADT sensitivity is only 80–90%, missing 10–20% of true infections. 1, 2
- Adults: A negative RADT alone is sufficient to rule out Group A Streptococcus; no backup culture is needed given the 5–10% prevalence and extremely low risk of acute rheumatic fever. 1, 2
- Children under 3 years: Do not test routinely, as streptococcal pharyngitis and acute rheumatic fever are rare in this age group, except when an older sibling has confirmed infection. 1, 2
When NOT to Test
- Do not test when viral features are present: cough, rhinorrhea, hoarseness, conjunctivitis, or oral ulcers strongly indicate viral etiology. 1, 2
- Test only when bacterial features predominate: sudden-onset sore throat, fever, tonsillar exudates, tender anterior cervical lymphadenopathy, and absence of viral signs. 1, 2, 3
First-Line Antibiotic Therapy (Non-Allergic Patients)
Penicillin V or amoxicillin for a full 10 days is the definitive first-line regimen, offering proven efficacy in preventing acute rheumatic fever, zero documented resistance worldwide, narrow spectrum, excellent safety, and low cost. 1, 4, 3
Specific Dosing Regimens
| Population | Drug & Dose | Duration |
|---|---|---|
| Adults | Penicillin V 500 mg orally twice daily | 10 days |
| Children ≥27 kg | Penicillin V 500 mg orally twice daily | 10 days |
| Children <27 kg | Penicillin V 250 mg orally 2–3 times daily | 10 days |
| All ages | Amoxicillin 50 mg/kg once daily (max 1000 mg) or 25 mg/kg twice daily (max 500 mg/dose) | 10 days |
Intramuscular Option for Adherence Concerns
- Benzathine penicillin G: Single IM dose of 600,000 units (<27 kg) or 1.2 million units (≥27 kg) guarantees complete treatment when oral adherence is doubtful. 1, 4
Critical Treatment Duration
A complete 10-day course is mandatory to achieve maximal pharyngeal eradication and prevent acute rheumatic fever; shortening the course by even 2–3 days markedly increases treatment failure and rheumatic fever risk. 1, 4, 6
- Therapy initiated within 9 days of symptom onset still effectively prevents acute rheumatic fever. 1, 2
- The primary goal is prevention of acute rheumatic fever and suppurative complications, not merely symptom relief. 1, 3, 7
Alternatives for Penicillin-Allergic Patients
Non-Immediate (Delayed) Penicillin Allergy
First-generation cephalosporins are the preferred alternatives, with strong, high-quality evidence and only ~0.1% cross-reactivity risk in patients with delayed, mild penicillin reactions. 1, 4
| Drug | Adult Dose | Pediatric Dose | Duration |
|---|---|---|---|
| Cephalexin | 500 mg orally twice daily | 20 mg/kg twice daily (max 500 mg/dose) | 10 days |
| Cefadroxil | 1 g orally once daily | 30 mg/kg once daily (max 1 g) | 10 days |
Immediate/Anaphylactic Penicillin Allergy
All β-lactam antibiotics (including cephalosporins) must be avoided because cross-reactivity can reach 10% in patients with immediate hypersensitivity reactions such as anaphylaxis, angioedema, or urticaria within 1 hour of exposure. 1, 4
Preferred Non-β-Lactam Alternative
Clindamycin is the optimal choice, with only ~1% resistance among U.S. Group A Streptococcus isolates and superior eradication rates even in chronic carriers. 1, 4
| Drug | Adult Dose | Pediatric Dose | Duration |
|---|---|---|---|
| Clindamycin | 300 mg orally three times daily | 7 mg/kg three times daily (max 300 mg/dose) | 10 days |
Macrolide Alternatives (Less Preferred)
- Azithromycin: 500 mg once daily for 5 days (adults) or 12 mg/kg once daily (max 500 mg) for 5 days (children); the only antibiotic requiring just 5 days due to prolonged tissue half-life. 1, 4, 8
- Clarithromycin: 250 mg twice daily for 10 days (adults) or 7.5 mg/kg twice daily (max 250 mg/dose) for 10 days (children). 1, 4
- Macrolide resistance in the United States ranges from 5–8% and varies geographically, making clindamycin more reliable when β-lactams cannot be used. 1, 4, 8
Management of Treatment Failure or Recurrent Infection
If initial therapy with penicillin or amoxicillin fails despite confirmed compliance, switch to clindamycin or amoxicillin-clavulanate, which achieve substantially higher eradication rates in chronic carriers and persistent infections. 1, 4
Alternative Regimens for Documented Failure
| Regimen | Dosing | Duration |
|---|---|---|
| Clindamycin | 20–30 mg/kg/day divided three times daily (max 300 mg/dose) | 10 days |
| Amoxicillin-clavulanate | 40 mg amoxicillin/kg/day divided three times daily (max 2000 mg amoxicillin/day) | 10 days |
| Penicillin V + rifampin | Penicillin V 50 mg/kg/day in four doses (max 2000 mg/day) × 10 days plus rifampin 20 mg/kg/day once daily for final 4 days (max 600 mg/day) | 10 days total |
Distinguishing Chronic Carriage from True Recurrence
- Most patients with multiple culture-positive episodes are chronic carriers experiencing concurrent viral infections rather than true recurrent streptococcal infections. 1, 4
- Chronic carriers generally do not require treatment unless special circumstances exist (e.g., community outbreak of rheumatic fever, family history of rheumatic fever, or excessive family anxiety). 1, 4
- Routine post-treatment cultures are unnecessary for asymptomatic patients; positive results often reflect carrier status rather than treatment failure. 1, 2, 4
Common Pitfalls to Avoid
- Do not prescribe antibiotics based solely on clinical appearance (e.g., tonsillar exudates or white patches), as these findings occur in both viral and bacterial infections. 1, 2
- Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk. 1, 4, 6
- Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to ~10% cross-reactivity risk. 1, 4
- Do not test or treat asymptomatic household contacts; up to one-third may be carriers, and prophylactic treatment does not reduce subsequent infection rates. 1, 2
- Do not prescribe trimethoprim-sulfamethoxazole for strep throat; it fails to eradicate Group A Streptococcus in 20–25% of cases. 1, 4